Ring Containment & Transmission Network

12 Tracked Individuals across 3 Transmission Tiers
R_effective: 0.38 (Contained)
Quarantined: 10 / 12
Remaining Window: 17 Days
Index Case (Isolated) Tier 1 Contact (High Risk) Tier 2 Secondary Transit Monitored & Asymptomatic Ring Vaccinated
Drag nodes to inspect contact links

21-Day Observation Progress 19% Complete

Day 4
/ 21-day viral hemorrhagic fever cutoff

Estimated secondary attack risk: 2.8% if monitored contacts develop febrile onset in strict isolation.

Secondary Ring Buffer Safe Barrier

0 Unreached
from 11 close contacts

Prophylactic vaccine ring protects 8 of 11 downstream contacts against secondary spillover.

Active Contact Surveillance Register

ID / Entity Exposure Category Exposure Date Monitoring Day Temp & Symptoms Surveillance Status
Ready: Baseline Nairobi imported case profile loaded. All 12 primary and secondary contacts registered.

Standard Operating Procedures for Imported Viral Hemorrhagic Fever (VHF) Surveillance

How public health rapid response teams isolate index arrivals, map travel itineraries across transit hubs, and enforce the 21-day incubation window.

The Cross-Border Tracing Chain

When an imported Ebola case arrives via multi-leg transport (such as overland transit from the DRC through Uganda before entering Kenya), transmission risk hinges on whether the patient was symptomatic during movement. Ebola virus disease (EVD) is non-transmissible during the incubation phase prior to fever, vomiting, diarrhea, or hemorrhage.

Contact tracing categorizes exposure vectors into three concentric tiers:

  • 1
    Direct Contact (Tier 1): Family members, physical caretakers, ambulance teams, and healthcare workers without specialized PPE who touched bodily fluids or contaminated bedding.
  • 2
    Transit Proximity (Tier 2): Passengers sharing enclosed transport (buses, aircraft rows, border queue checkpoints) within 1 meter for prolonged intervals.
  • 3
    Secondary Ring (Tier 3): Casual contacts and downstream household members of primary contacts, targeted for preemptive monitoring and ring vaccination.

The 21-Day Incubation & Discharge Rules

The incubation period for Ebola virus spans from 2 to 21 days (mean: 8 to 11 days). Public health regulations dictate that any person with confirmed exposure must undergo twice-daily temperature checks and symptom surveillance for a full 21 consecutive days following the last documented contact.

Key protocol thresholds evaluated in this simulator:

  • A
    Immediate Triaged Isolation: If a contact records a tympanic or oral temperature ≥38.0°C (100.4°F) or exhibits fatigue, headache, or nausea, they must be isolated immediately in a designated holding ward before PCR testing.
  • B
    Ring Vaccination (rVSV-ZEBOV): Prophylactic immunization given to primary contacts and contacts-of-contacts within 48 to 72 hours creates an immune buffer, truncating R_effective to below 0.4.
  • C
    Day-21 Cohort Discharge: If 21 complete days pass without symptoms, the individual is medically cleared and removed from active surveillance registries.

Frequently Asked Questions

Can asymptomatic travelers transmit the virus on an airplane or bus?

No. Extensive clinical data from the WHO, CDC, and African CDC confirms that individuals in the incubation phase who are not exhibiting symptoms do not shed sufficient virus to transmit infection. Risk begins strictly with symptom onset.

What defines effective contact tracing coverage in an urban import?

A coverage threshold ≥80% of identified primary contacts under active monitoring within 24 hours is considered the international benchmark required to prevent community secondary amplification.

How does the rVSV-ZEBOV ring vaccination strategy work?

Rather than mass population immunization, ring vaccination creates a protective circle around each infected patient by vaccinating all close contacts and their secondary circles, rapidly choking transmission chains.

How is this simulation calculated?

This model combines stochastic branching processes with empirical incubation distributions (Weibull shape α=2.4, scale β=9.2 days) adjusted for intervention lag, tracing completeness, and vaccine efficacy.